5 Free Dividend Stocks for 2022
Could these top payout stocks be part of the greatest wealth-creating tool in history?
Learn More.
Sammy Karam, insider at Abbott Laboratories
Sammy Karam Insider Alerts

Get notified the next time Sammy Karam buys or sells Abbott Laboratories stock. Enter your email address below to get our daily insider buying and selling report.

Sammy Karam Insider Information

In his role as Senior Vice President, Emerging Markets in Abbott's branded medicines business, Sammy ensures access to Abbott’s medicines and brands in the world's fastest-growing regions.

Prior to assuming this position in February 2019, Sammy served as Divisional Vice President, Global Marketing and Commercial Execution.

He joined Abbott in 2014, having previously served as Vice President Europe for Omega Pharma (now Perrigo).

In his Abbott career, Sammy has built on our company's longstanding focus on commercial execution, strengthening his marketing team, building our portfolio of sustainable brands, and driving above-market growth in his areas of responsibility.

Sammy earned his Master of Business Administration degree, with an emphasis in Marketing and International Business, from the University of Texas at Arlington and his Bachelor of Science in Accounting from Minnesota State University. He has also followed executive education programs with Harvard, Stanford, and Northwestern Business schools.

What is Sammy Karam's net worth?

The estimated net worth of Sammy Karam is at least $3.90 million as of August 17th, 2021. Mr. Karam owns 30,926 shares of Abbott Laboratories stock worth more than $3,898,222 as of January 20th. This net worth evaluation does not reflect any other investments that Mr. Karam may own. Learn More.

How do I contact Sammy Karam?

The corporate mailing address for Mr. Karam and other Abbott Laboratories executives is 100 ABBOTT PARK ROAD D-322 AP6D, ABBOTT PARK IL, 60064. Abbott Laboratories can also be reached via phone at (224) 667-6100.

Has Sammy Karam been buying or selling shares of Abbott Laboratories?

Sammy Karam has not been actively trading shares of Abbott Laboratories in the last ninety days. Most recently, Sammy Karam sold 4,700 shares of the business's stock in a transaction on Thursday, December 23rd. The shares were sold at an average price of $140.00, for a transaction totalling $658,000.00.

Who are Abbott Laboratories' active insiders?

Abbott Laboratories' insider roster includes Philip Boudreau (VP), Michael Dale (SVP), Sammy Karam (SVP), Andrew Lane (EVP), Michael Pederson (SVP), Andrea Wainer (EVP), Jared Watkin (SVP), and Randel Woodgrift (SVP).

Are insiders buying or selling shares of Abbott Laboratories?

During the last year, Abbott Laboratories insiders bought shares 1 times. They purchased a total of 2,040 shares worth more than $249,900.00. During the last year, insiders at the healthcare product maker sold shares 25 times. They sold a total of 429,551 shares worth more than $54,007,291.72. The most recent insider tranaction occured on December, 27th when EVP Andrea F Wainer sold 3,000 shares worth more than $427,500.00. Insiders at Abbott Laboratories own 1.5 % of the company.

Information on this page was last updated on 12/27/2021.

Sammy Karam Insider Trading History at Abbott Laboratories

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/23/2021Sell4,700$140.00$658,000.00View SEC Filing Icon  
8/17/2021Sell8,000$125.00$1,000,000.0030,926View SEC Filing Icon  
8/3/2021Sell8,000$122.50$980,000.00View SEC Filing Icon  
See Full Table

Sammy Karam Buying and Selling Activity at Abbott Laboratories

This chart shows Sammy Karam's buying and selling at Abbott Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Abbott Laboratories Company Overview

Abbott Laboratories logo
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Read More

Today's Range

Now: $126.05
Low: $125.83
High: $127.58

50 Day Range

MA: $132.45
Low: $124.48
High: $141.46

2 Week Range

Now: $126.05
Low: $105.36
High: $142.60

Volume

3,996,077 shs

Average Volume

6,444,879 shs

Market Capitalization

$222.89 billion

P/E Ratio

31.28

Dividend Yield

1.49%

Beta

0.72
5 Free Dividend Stocks for 2022
Could these top payout stocks be part of the greatest wealth-creating tool in history?
Learn More.